Article
The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory
2018-06-18
Abstract excerpt
An upcoming clinical trial at the Moffitt Cancer Center for women with stage 2/3 ER+breast cancer combines an aromatase inhibitor and a PD-L1 checkpoint inhibitor, and aims to lower a preoperative endocrine prognostic index (PEPI) that correlates with relapse-free survival. PEPI is fundamentally a static index, measured at the end of neoadjuvant therapy before surgery. We develop a mathematical model of the essent...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 76d3d36c-e70f-5aaa-b146-cd3f25dadea3
- DOI
- 10.1101/349142
